BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2005
View Archived Issues
XTLbio signs license and asset purchase agreement with VivoQuest
Read More
Health Canada clearance for phase IIb study of AeroLEF for acute pain
Read More
Phase II data on the effects of Bronchitol in cystic fibrosis
Read More
CADA - a potential anti-HIV CD4-targeting microbicide
Read More
Preclinical data on seliciclib activity against MCL cell lines
Read More
Spotlight on pregabalin from the 11th World Congress on Pain
Read More
Good phase I results reported for oral RSD-1235 in healthy subjects
Read More
An herbal drug reported effective in the treatment of IAR
Read More
sanofi-aventis presents round-up of recent events
Read More
Clinical data on lenalidomide in CRPS type 1 patients
Read More
More evidence required for diagnosis of metabolic syndrome
Read More
Biken receives Japanese approval for combined measles-rubella vaccine
Read More
Approvable letter for Dacogen for myelodysplastic syndromes
Read More
Astex establishes new drug discovery collaboration with Boehringer Ingelheim
Read More
FDA advisory committee to consider abatacept infection, malignancy risk
Read More
Amgen to study darbepoetin alfa in treating anemia in heart failure patients
Read More
SkyePharma in negotiations over Flutiform
Read More
Roche seeks European approval for MabThera in rheumatoid arthritis
Read More
Immunomodulatory effects reported for ES-62 in a preclinical model of asthma
Read More
Phase I data on the effects of SB-485232 in renal cell carcinoma and multiple myeloma
Read More
Fondaparinux reported effective in the treatment of acute coronary syndromes
Read More
Novel agents for diabetes and related complications reported in recent patent literature
Read More
AEG-33690 will enter clinical testing for chemotherapy-induced neuropathy
Read More
Novel agents for alopecia claimed by Pfizer
Read More
Novel anti-HIV agents reported by Shionogi and AstraZeneca
Read More